Intersection of oncology treatments and cardiovascular health

Abstract

ABSTRACT

In recent years, significant advances in cancer treatment have been observed, but these treatments have also increased the risk of cardiovascular complications. Cardio-oncology has emerged as a field dedicated to the monitoring and cardiovascular care of cancer patients, with the aim of early identification cardiac problems and provide appropriate interventions to minimize adverse impacts. The use of cardiac biomarkers such as troponins plays a key role in early detection and monitoring of cardiac toxicity throughout treatment. Integrated monitoring and intervention strategies, including the use of angiotensin conversion inhibitors to prevent adverse ventricular remodeling, are essential to improve long-term cardiovascular and oncological outcomes for patients.